In vivo studies of opiate receptors.
To study opiate receptors noninvasively in vivo using positron emission tomography, techniques for preferentially labeling opiate receptors in vivo can be used. The rate at which receptor-bound ligand clears from the brain in vivo can be predicted by measuring the equilibrium dissociation constant (KD) at 37 degrees C in the presence of 100 mM sodium chloride and 100 microM guanyl-5'-imidodiphosphate, the drug distribution coefficient, and the molecular weight. A suitable ligand for labeling opiate receptors in vivo is diprenorphine, which binds to mu, delta, and kappa receptors with approximately equal affinity in vitro. However, in vivo diprenorphine may bind predominantly to one opiate receptor subtype, possibly the mu receptor. To predict the affinity for binding to the opiate receptor, a Hansch correlation was determined between the 50% inhibitory concentration for a series of halogen-substituted fentanyl analogs and electronic, lipophilic, and steric parameters. Radiochemical methods for the synthesis of carbon-11-labeled diprenorphine and lofentanil are presented.
D001921:Brain / Q000378:metabolism; D002250:Carbon Radioisotopes; D004174:Diprenorphine; D004339:Drug Compounding; D005283:Fentanyl / Q000031:analogs & derivatives; D006801:Humans; D011849:Radioactive Tracers; D011957:Receptors, Opioid / Q000378:metabolism*; D013329:Structure-Activity Relationship; D014055:Tomography, Emission-Computed
D002250:Carbon Radioisotopes; D011849:Radioactive Tracers; D011957:Receptors, Opioid; D004174:Diprenorphine; C034846:lofentanil; D005283:Fentanyl